FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to an anti-FLT3 antibody or its antigen-binding part, a composition containing it, as well as to a method for production thereof. Also disclosed is an isolated nucleic acid molecule coding said antibody, as well as a cell and a vector containing same.
EFFECT: invention is effective for treating cancer, as well as for treating an immunological disorder in a patient in need thereof.
28 cl, 13 dwg, 8 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED ANTI-FLT3 ANTIGEN-BINDING PROTEINS | 2019 |
|
RU2830982C2 |
| ANTIBODIES SPECIFIC TO FLT3 AND THEIR APPLICATIONS | 2018 |
|
RU2758513C2 |
| CHIMERIC ANTIGENE RECEPTORS TARGETTING FLT3 | 2018 |
|
RU2820859C2 |
| ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF | 2020 |
|
RU2831838C2 |
| TETANUS TOXIN ANTIBODY AND USE THEREOF | 2020 |
|
RU2815280C1 |
| BISPECIFIC ANTI-EGFR/ANTI-4-1BB ANTIBODY AND USE THEREOF | 2020 |
|
RU2831836C2 |
| BISPECIFIC ANTIBODY AGAINST CD3E/BCMA AND ITS USE | 2019 |
|
RU2800164C2 |
| ANTIGEN-BINDING POLYPEPTIDE BINDING TO CD47, AND USE THEREOF | 2021 |
|
RU2833294C2 |
| AMATOXIN ANTIBODY-DRUG CONJUGATES AND USE THEREOF | 2020 |
|
RU2826004C2 |
| BISPECIFIC ANTIGEN-BINDING MOLECULES CONTAINING ANTI-FAP CLONE 212 | 2019 |
|
RU2799429C2 |
